ArticleMedicine and pharmacy reports2025
Adrenal incidentalomas: clinical, biological, imaging and therapeutic features.
Article in Medicine and pharmacy reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Specialist consultation improves underdiagnosis of surgical adrenal incidentaloma: a TriNetX database investigation.The Canadian journal of urology · 2026Article
- A longitudinal study of dual-energy X-ray absorptiometry status in menopausal women with adrenal tumors.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologieArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adrenal incidentaloma is an adrenal mass discovered incidentally during an imaging examination that was not conducted to investigate an adrenal pathology. Its etiologies are varied, which determines the choice of different therapeutic options. The objective of our study is to describe the clinical, biological, etiological, and therapeutic aspects of adrenal incidentalomas in our series. Methods: This is a retrospective study including 55 patients who were managed for adrenal incidentalomas. Demographic characteristics, clinical evaluations, imaging features, and functional status were analyzed. Results: The mean age was 55.49 ± 13.53 years with a female predominance (65.4%). The circumstances of discovery were predominantly digestive (54.5%). Computed tomography (CT) was the most frequent imaging method used in the first detection of adrenal incindentalomas. These adrenal masses were unilateral in 72.8% of patients, and bilateral in 27.2% of cases. Their sizes ranged from 10 to 135 mm. In terms of secretory profile, the etiologies of adrenal incidentalomas were predominantly non-functional, followed by pheochromocytomas, and hypercortisolism, then primary hyperaldosteronism. Adrenalectomy was indicated for 23.6% of our patients. Conclusion: Our results are in agreement with those in the literature, showing that patients with an incidental adrenal mass need a multidisciplinary approach involving clinical and biological screening for endocrine hypersecretion, as well as radiological evaluation to ensure an effective etiological diagnosis and to establish a personalized and optimal therapeutic management plan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.